Larimar Therapeutics Inc
NASDAQ:LRMR
Larimar Therapeutics Inc
NASDAQ:LRMR
Price:
4.85
USD
-4.72%
Market Closed
Market Cap:
$502.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
Grupo Aeroportuario del Pacifico SAB de CV
F:G9N
|
MX |
Balance Sheet
Balance Sheet Decomposition
Larimar Therapeutics Inc
Larimar Therapeutics Inc
Balance Sheet Decomposition is not available for
Larimar Therapeutics Inc
Larimar Therapeutics Inc
Balance Sheet
Larimar Therapeutics Inc
Larimar Therapeutics Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
10
|
36
|
58
|
36
|
32
|
41
|
49
|
27
|
68
|
70
|
27
|
27
|
33
|
85
|
|
| Cash Equivalents |
10
|
36
|
58
|
36
|
32
|
41
|
49
|
27
|
68
|
70
|
27
|
27
|
33
|
85
|
|
| Short-Term Investments |
0
|
0
|
57
|
149
|
97
|
61
|
69
|
43
|
24
|
0
|
92
|
60
|
150
|
51
|
|
| Total Receivables |
0
|
2
|
0
|
1
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
1
|
2
|
2
|
1
|
5
|
2
|
2
|
3
|
11
|
4
|
|
| Total Current Assets |
10
|
37
|
117
|
188
|
131
|
105
|
121
|
72
|
98
|
72
|
121
|
90
|
195
|
142
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
8
|
5
|
4
|
4
|
4
|
4
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
8
|
5
|
4
|
4
|
4
|
4
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Total Assets |
11
N/A
|
38
+247%
|
118
+208%
|
189
+61%
|
132
-30%
|
106
-20%
|
122
+15%
|
81
-34%
|
105
+30%
|
79
-25%
|
126
+61%
|
96
-24%
|
200
+109%
|
146
-27%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
1
|
2
|
2
|
7
|
3
|
3
|
4
|
1
|
3
|
2
|
2
|
1
|
2
|
5
|
|
| Accrued Liabilities |
2
|
1
|
3
|
6
|
4
|
4
|
4
|
4
|
6
|
7
|
9
|
8
|
22
|
60
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
3
|
3
|
0
|
5
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
7
|
17
|
10
|
7
|
13
|
12
|
9
|
9
|
11
|
10
|
24
|
65
|
|
| Long-Term Debt |
0
|
0
|
6
|
3
|
0
|
20
|
15
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
5
|
5
|
5
|
4
|
3
|
|
| Total Liabilities |
3
N/A
|
3
-1%
|
13
+349%
|
20
+53%
|
10
-51%
|
27
+176%
|
28
+4%
|
27
-5%
|
15
-45%
|
14
-5%
|
16
+9%
|
14
-8%
|
28
+100%
|
68
+138%
|
|
| Equity | |||||||||||||||
| Common Stock |
63
|
104
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
55
|
69
|
105
|
180
|
238
|
290
|
351
|
396
|
66
|
116
|
152
|
189
|
269
|
435
|
|
| Additional Paid In Capital |
0
|
0
|
210
|
349
|
359
|
368
|
444
|
450
|
155
|
181
|
262
|
270
|
441
|
513
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
35
+337%
|
104
+197%
|
169
+62%
|
122
-28%
|
78
-36%
|
93
+19%
|
54
-43%
|
90
+67%
|
64
-28%
|
111
+72%
|
82
-26%
|
172
+110%
|
78
-55%
|
|
| Total Liabilities & Equity |
11
N/A
|
38
+247%
|
118
+208%
|
189
+61%
|
132
-30%
|
106
-20%
|
122
+15%
|
81
-34%
|
105
+30%
|
79
-25%
|
126
+61%
|
96
-24%
|
200
+109%
|
146
-27%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
15
|
18
|
43
|
44
|
64
|
83
|
|
Switch to:
Switch to:
See Also
Discover More
